Final MQSA provisions go into effect
After seven years of phased-in implementation, the final provision of the Mammography Quality Standards Act (MQSA) went into effect April 28. The last rule to become law addresses patients’ rights to obtain documentation of test results,
After seven years of phased-in implementation, the final provision of the Mammography Quality Standards Act (MQSA) went into effect April 28. The last rule to become law addresses patients rights to obtain documentation of test results, ensuring that women who have mammograms will be directly notified in writing. The provision was added to the final regulations that implement MQSA, and reflects updates on the law made by the Mammography Quality Standards Reauthorization Act of 1998. The FDA estimates that most of the 10,000 U.S. mammography facilities have already met MQSA standards and are certified to perform mammography exams.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
